This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Passiflora incarnata flower is a herbal product indicated in the treatment of stress, nervousness, anxiety, irritability, and trouble sleeping.
- Generic Name
- Passiflora incarnata flower
- DrugBank Accession Number
- DB13974
- Background
Not Available
- Type
- Biotech
- Groups
- Approved, Experimental
- Synonyms
- Passiflora incarnata flower dry extract
- Passiflora incarnata flower extract
- Passion flower
- Passion flower extract
- Purple passionflower
- True passionflower
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Symptomatic treatment of Irritability ••• ••• ••••••• •••••• Symptomatic treatment of Mental stress ••• ••• ••••••• •••••• Symptomatic treatment of Nervousness ••• ••• ••••••• •••••• Symptomatic treatment of Sleep disorders and disturbances ••• ••• ••••••• •••••• Symptomatic treatment of Acute anxiety ••• ••• ••••••• •••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Effidose Passiflore Liq 2396mg/10ml Amp Liquid 2.396 g / amp Oral Laboratoires Charton Laboratories 1995-12-31 1999-01-16 Canada 
Florasun Passiflore Cap 230mg Capsule 230 mg / cap Oral Laboratoire Lalco Inc. 1993-12-31 2000-08-01 Canada Nervosite - Cap 230mg Capsule 230 mg / cap Oral Laboratoire Lalco Inc. 1997-01-20 2002-09-05 Canada Passiflore Natura Medica Liquid 1 g / 10 mL Oral Dolisos Laboratoires S.A. 1997-08-04 1999-08-12 Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Bio-strath No. 8 Gouttes Passiflora incarnata flower (0.225 mL / mL) + Peppermint (0.05 mL / mL) + Valerian (0.225 mL / mL) Solution / drops Oral Bio Strath Ag 1989-12-31 2008-07-24 Canada Dormiphen Au Naturel Passiflora incarnata flower (400 mg) + Valerian (400 mg) Capsule Oral Laboratoire Lalco Inc. Not applicable Not applicable Canada Herbal Sleep Passiflora incarnata flower (175 mg) + Chamomile (100 mg) + Hops (165 mg) + Valerian (600 mg) Capsule Oral Puresource Inc. Not applicable Not applicable Canada Herbal Sleep Aid Passiflora incarnata flower (100 mg) + Hops (100 mg) + Valerian (400 mg) Capsule Oral Wampole Brands, A Division Of Pangeo Pharma (Canada) Inc. 1998-11-05 2002-07-29 Canada Lapidar 7 Tab Passiflora incarnata flower (3.5 mg) + Valerian (74.5 mg) Tablet Oral Swiss Herbal Remedies Ltd. 1976-12-31 1998-07-15 Canada
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- SY49TH8VUA
- CAS number
- Not Available
References
- General References
- AIFA Package Leaflet: TRACTANA (Passiflora incarnata flower) oral tablet [Link]
- External Links
- 1355833
- Wikipedia
- Passiflora_incarnata
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution / drops Oral Liquid Oral 2.396 g / amp Capsule Oral 230 mg / cap Capsule Oral Liquid Oral 1 g / 10 mL Tablet Oral Tablet, coated Oral 200 mg Liquid Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
Drug created at January 17, 2018 22:53 / Updated at April 18, 2024 09:15